Risk factors for severe and critically ill COVID‐19 patients: a review

Y Gao, M Ding, X Dong, J Zhang, A Kursat Azkur… - Allergy, 2021 - Wiley Online Library
The pandemic of coronavirus disease 2019 (COVID‐19), caused by the severe acute
respiratory syndrome coronavirus 2 (SARS‐CoV‐2), has caused an unprecedented global …

Clinical, radiological, and laboratory characteristics and risk factors for severity and mortality of 289 hospitalized COVID‐19 patients

J Zhang, Y Cao, G Tan, X Dong, B Wang, J Lin, Y Yan… - Allergy, 2021 - Wiley Online Library
Background The coronavirus disease 2019 (COVID‐19) has become a global pandemic,
with 10%‐20% of severe cases and over 508 000 deaths worldwide. Objective This study …

Immune response to SARS‐CoV‐2 and mechanisms of immunopathological changes in COVID‐19

AK Azkur, M Akdis, D Azkur, M Sokolowska… - Allergy, 2020 - Wiley Online Library
As a zoonotic disease that has already spread globally to several million human beings and
possibly to domestic and wild animals, eradication of coronavirus disease 2019 (COVID‐19) …

A compendium answering 150 questions on COVID‐19 and SARS‐CoV‐2

C Riggioni, P Comberiati, M Giovannini, I Agache… - Allergy, 2020 - Wiley Online Library
Abstract In December 2019, China reported the first cases of the coronavirus disease 2019
(COVID‐19). This disease, caused by the severe acute respiratory syndrome–related …

COVID‐19: risk factors associated with infectivity and severity

N Fadl, E Ali, TZ Salem - Scandinavian Journal of Immunology, 2021 - Wiley Online Library
COVID‐19 is highly transmissible; however, its severity varies from one individual to
another. Variability among different isolates of the virus and among its receptor (ACE2) may …

Interrelations between COVID-19 and other disorders

A Gasmi, M Peana, L Pivina, S Srinath… - Clinical …, 2021 - Elsevier
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a respiratory tract
virus that causes Coronavirus disease (COVID-19). The virus originated in Wuhan, China, in …

Immunity and inflammatory biomarkers in COVID‐19: a systematic review

APD Iwamura, MR Tavares da Silva… - Reviews in medical …, 2021 - Wiley Online Library
Summary Coronavirus disease 2019 (COVID‐19) is a clinical syndrome caused by the
severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) virus. Patients can be …

Distinct cytokine profiles associated with COVID-19 severity and mortality

K Dorgham, P Quentric, M Gökkaya, S Marot… - Journal of Allergy and …, 2021 - Elsevier
Background Markedly elevated levels of proinflammatory cytokines and defective type-I
interferon responses were reported in patients with coronavirus disease 2019 (COVID-19) …

Immune-epidemiological parameters of the novel coronavirus–a perspective

A Saghazadeh, N Rezaei - Expert review of clinical immunology, 2020 - Taylor & Francis
Introduction At the end of 2019, Wuhan, a city in China with a population of about 11 million,
witnessed the outbreak of unusual pneumonia. As of 29 March 2020, the disease has …

Immunology of COVID‐19: mechanisms, clinical outcome, diagnostics, and perspectives—a report of the European Academy of Allergy and Clinical Immunology …

M Sokolowska, ZM Lukasik, I Agache, CA Akdis… - Allergy, 2020 - Wiley Online Library
With the worldwide spread of the novel severe acute respiratory syndrome coronavirus‐2
(SARS‐CoV‐2) resulting in declaration of a pandemic by the World Health Organization …